Knowing when to ship is the hard part.

Building a better model isn't the final decision. Deciding when it's ready for real users is.

A team gives it a slice of traffic first — say, 25% — and watches. Then someone has to decide: keep going, hold, or pull it back.

That call depends on four things — is it accurate, is it safe, is it usable, is it stable. I built one place to see all four together.

Overall, the new model looked healthy. One user group told a different story.

An answer "without enough evidence" just means the model made a claim it couldn't really back up.

One decision depends on five sources of evidence.

Before a team expands a rollout, they have to check a lot of things: model tests, safety signals, experiments, system performance, moderation alerts.

Those all live in different tools.

So I asked a simple question: what if they all lived in one place instead?

Four people, one decision.

Can we safely give the new model more traffic?

Four questions, not one score.

Every metric comes with a tradeoff. There's no single score — just four areas, checked on their own, every time.

If a number can't answer these questions, it doesn't get shown. Here's a real example from the story above — the Spanish-language legal and financial group. Fictional Data — Product Concept Illustration

Same regression as before. Logged as a missing test — not just a bad result.

Why the rollout paused.

Nothing here moves forward just because time passed. It moves when there's enough proof. Fictional Data — Product Concept Illustration

Five screens. One rollout decision.

The experience follows one model rollout from the first warning to the final recorded decision. Each screen answers the next question the team needs to resolve. Fictional Data — Product Concept Illustration

01 — Detect

01

Rollout Overview

"What stopped the rollout?"

The overview brings the current rollout stage, readiness requirements, health areas, and blocking issue into one place. Most signals look healthy, but one user group has crossed a quality limit.

Why it matters. The screen prevents an overall improvement from hiding a meaningful group-level regression.

Full Interface

Decision Spotlight

The rollout appeared ready to expand until the dashboard surfaced one group whose unsupported claims rose from 5.2% to 8.9%.

What this shows. I designed the overview around the reason the rollout cannot advance — not around a generic collection of KPIs.

A Quick Recap Before Comparing

02 — Compare

02

Compare Health Areas

"Which part of product health is blocking the rollout?"

This screen compares the new model with the current model across quality, safety, user experience, and reliability. Each area stays separate so one strong result can't cancel out a meaningful regression elsewhere.

Why it matters. A rollout shouldn't get one overall health score. The team needs to see where performance improved, where it stayed stable, and where it failed.

Full Interface

What this shows. I treated product health as a set of connected tradeoffs rather than one simplified score.

03 — Investigate

03

Investigation Case

"What do we know, and what still needs to be proven?"

The investigation separates confirmed observations from a working explanation. It records what changed, what the team currently believes, which alternatives have been ruled out, and what evidence is still missing.

Why it matters. The interface helps the team reason under uncertainty without presenting a coincidence as proven causation.

Full Interface

Decision Spotlight

The team has a likely explanation, but the dashboard keeps the uncertainty visible. A missing test may explain why the problem went undetected — without proving what caused it.

What this shows. I designed AI and analytical support to expose uncertainty — not conceal it behind a confident answer.

04 — Prepare

04

Investigate the Alert

"What changed?"

This is where the team gathers what's been learned so far — the evidence collected, the explanations considered, and what's still unresolved. Before anyone recommends advancing or holding, the review has to be based on what's actually known, not the first plausible story.

Why it matters. A final decision should be based on reviewed evidence, not on the loudest alert or the first plausible explanation.

Full Interface

What this shows. I designed a clear handoff from investigation to accountable decision-making.

05 — Decide

05

Decision Record

"What did the team decide, and what happens next?"

The final screen records the selected action, rationale, owners, approvals, unresolved uncertainty, and required follow-up. In this scenario, the team maintains the rollout at 25% and authorizes a controlled retest.

Why it matters. Finding a regression isn't the end of the product workflow. The evidence has to become an accountable decision with a clear next step.

Full Interface

Decision Spotlight

The team holds the rollout at 25% and requires a controlled retest before reconsidering expansion.

What this shows. I designed the decision as a permanent, human-owned product artifact — not an AI-generated recommendation that disappears after the review.

AI organizes evidence. It doesn't own the decision.

How I'd know if this is working.

North Star: Catch meaningful problems before the model reaches more users.

Nothing here has been measured yet. This is the plan for finding out — have a few PMs, researchers, and safety reviewers work through this same story and see if they land on the same call.

What ships first.

It only grows once this one workflow proves it actually helps.

I started designing a dashboard. I ended up designing a decision.

More data wasn't the answer. The harder problem was helping a team see the tradeoffs without hiding the uncertainty — no single score, no metric without its context, no AI explanation without its evidence.

The best version of this isn't the one that makes model health look simple. It's the one that helps a team understand why they should wait.

"Good internal tools do not remove uncertainty. They make it easier to act responsibly in spite of it."